Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff S Higgins

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|November 16, 2016
A new roadmap to improve translation of imaging biomarkersMichael Skwarski, Geoff S Higgins
British Journal of Cancer|February 24, 2022
Elucidating the role of transiently hypoxic tumour cells on radiation resistanceGeoff S Higgins, Ester M Hammond
Science (New York, N.Y.)|March 29, 2018
Beyond PARP-POLθ as an anticancer targetGeoff S Higgins, Simon J Boulton
The British Journal of Radiology|February 14, 2018
Targeting tumour hypoxia: shifting focus from oxygen supply to demandJames T Coates, Michael Skwarski, Geoff S Higgins
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
In Vitro-Pooled shRNA Screening to Identify Determinants of RadiosensitivityAlessandro Ceroni, Geoff S Higgins, Daniel V Ebner
European Journal of Cancer (Oxford, England : 1990)|August 21, 2019
Reply to 'The use of buparlisib as a radiosensitiser: What about toxicity?'Daniel R McGowan, Michael Skwarski, Geoff S Higgins
BMJ Oncology|January 31, 2025
Repurposing radiosensitising medicines for radiotherapy: an overviewJie Man Low, Gonzalo Rodriguez-Berriguete, Geoff S Higgins
British Journal of Cancer|February 26, 2022
Radiation-induced prodrug activation: extending combined modality therapy for some solid tumoursNicola J Farrer, Geoff S Higgins, Ian H Kunkler
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 20, 2016
Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase InhibitorsGeoff S Higgins, Mechthild Krause, W Gillies McKenna, et al.
Frontiers in Oncology|March 13, 2020
Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?Joseph D Wilson, Ester M Hammond, Geoff S Higgins, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|November 16, 2016
A new roadmap to improve translation of imaging biomarkersMichael Skwarski, Geoff S Higgins
British Journal of Cancer|February 24, 2022
Elucidating the role of transiently hypoxic tumour cells on radiation resistanceGeoff S Higgins, Ester M Hammond
Science (New York, N.Y.)|March 29, 2018
Beyond PARP-POLθ as an anticancer targetGeoff S Higgins, Simon J Boulton
The British Journal of Radiology|February 14, 2018
Targeting tumour hypoxia: shifting focus from oxygen supply to demandJames T Coates, Michael Skwarski, Geoff S Higgins
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
In Vitro-Pooled shRNA Screening to Identify Determinants of RadiosensitivityAlessandro Ceroni, Geoff S Higgins, Daniel V Ebner
European Journal of Cancer (Oxford, England : 1990)|August 21, 2019
Reply to 'The use of buparlisib as a radiosensitiser: What about toxicity?'Daniel R McGowan, Michael Skwarski, Geoff S Higgins
BMJ Oncology|January 31, 2025
Repurposing radiosensitising medicines for radiotherapy: an overviewJie Man Low, Gonzalo Rodriguez-Berriguete, Geoff S Higgins
British Journal of Cancer|February 26, 2022
Radiation-induced prodrug activation: extending combined modality therapy for some solid tumoursNicola J Farrer, Geoff S Higgins, Ian H Kunkler
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 20, 2016
Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase InhibitorsGeoff S Higgins, Mechthild Krause, W Gillies McKenna, et al.
Frontiers in Oncology|March 13, 2020
Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?Joseph D Wilson, Ester M Hammond, Geoff S Higgins, et al.
Pageof 6